Publications (139) PABLO AGUIAR FERNANDEZ publications

2024

  1. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  2. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

  3. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging

    European Journal of Nuclear Medicine and Molecular Imaging

2023

  1. A murine model of BSCL2-associated Celia's encephalopathy

    Neurobiology of Disease, Vol. 187

  2. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship

    Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454

  3. EANM position paper: theranostics in brain tumours—the present and the future

    European Journal of Nuclear Medicine and Molecular Imaging

  4. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective

    European Journal of Nuclear Medicine and Molecular Imaging

  5. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity

    JAMA neurology

  6. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

  7. Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia: Estudio GALIPEMIAS

    Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 4, pp. 178-184

  8. Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

    Journal of Controlled Release, Vol. 356, pp. 702-713

2022

  1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

  2. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  3. Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET

    Journal of Controlled Release, Vol. 347, pp. 500-507

  4. Impact of spill-in counts from off-target regions on [18F]Flortaucipir PET quantification

    NeuroImage, Vol. 259

  5. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. A systematic review of pet textural analysis and radiomics in cancer

    Diagnostics, Vol. 11, Núm. 2

  2. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  3. Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging

    International Journal of Nanomedicine, Vol. 16, pp. 5923-5935

  4. Computational Issues in the Application of Functional Data Analysis to Imaging Data

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)